| Intellectual property and medicine |
| Section A: Intellectual property of medicine and its sources |
| · International framework and history of intellectual property relevant to medicine |
| · Categories of intellectual property relevant to medicine |
| · European and National systems (UK and designated jurisdictions) |
| · Applications of intellectual property in medical and pharmaceutical industries |
| Section B: Access to medicines |
| · Overview of the issues and history of the campaign |
| · Human right to health and the ethics of patents |
| · TRIPS Agreement |
| · Doha Development Round (Ministerial Declaration; Declaration on TRIPS and Public Health; Decision on Paragraph 6) |
| · Paragraph 6 System |
| Section C: Patents and life forms |
| · Legal and socio-legal concept of life form |
| · Ethical considerations and exceptions |
| · Medical biotechnologies |
| · International, European and designated domestic frameworks (including European Biotechnology Directive) |
| · Genes and gene sequences |
| · Cloning |
| · Germ-line modification technology |
| · Embryos |
| Section D: Property in the person |
| · Medical and genetic privacy and intellectual property |
| · Genetic privacy |
| · Genetic sampling and collection; genomic libraries and databases |
| · Traditional medicine and genetic resources |
Sequence:
The sections must be attempted in order. |
Textbook:
Johanna Gibson, Intellectual Property and Medicine: Current Debates (London: Ashgate,
2009), ISBN: 0754672182 |
